UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis

NCT07109986 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus
Lupus Nephritis

Interventions

DRUG: UB-VV410

Sponsor

Nanjing IASO Biotechnology Co., Ltd.

Collaborators

[object Object]